1. Home
  2. FRES vs LTRY Comparison

FRES vs LTRY Comparison

Compare FRES & LTRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FRES
  • LTRY
  • Stock Information
  • Founded
  • FRES 2010
  • LTRY 2015
  • Country
  • FRES United States
  • LTRY United States
  • Employees
  • FRES N/A
  • LTRY N/A
  • Industry
  • FRES Medical Specialities
  • LTRY Computer Software: Prepackaged Software
  • Sector
  • FRES Health Care
  • LTRY Technology
  • Exchange
  • FRES Nasdaq
  • LTRY Nasdaq
  • Market Cap
  • FRES 6.4M
  • LTRY 8.8M
  • IPO Year
  • FRES 2020
  • LTRY N/A
  • Fundamental
  • Price
  • FRES $2.53
  • LTRY $1.82
  • Analyst Decision
  • FRES
  • LTRY
  • Analyst Count
  • FRES 0
  • LTRY 0
  • Target Price
  • FRES N/A
  • LTRY N/A
  • AVG Volume (30 Days)
  • FRES 10.9K
  • LTRY 321.4K
  • Earning Date
  • FRES 09-17-2024
  • LTRY 08-20-2024
  • Dividend Yield
  • FRES N/A
  • LTRY N/A
  • EPS Growth
  • FRES N/A
  • LTRY N/A
  • EPS
  • FRES N/A
  • LTRY N/A
  • Revenue
  • FRES $2,345,304.00
  • LTRY $6,626,564.00
  • Revenue This Year
  • FRES N/A
  • LTRY N/A
  • Revenue Next Year
  • FRES N/A
  • LTRY N/A
  • P/E Ratio
  • FRES N/A
  • LTRY N/A
  • Revenue Growth
  • FRES N/A
  • LTRY 75.84
  • 52 Week Low
  • FRES $2.36
  • LTRY $0.82
  • 52 Week High
  • FRES $41.00
  • LTRY $13.00
  • Technical
  • Relative Strength Index (RSI)
  • FRES 34.73
  • LTRY 72.08
  • Support Level
  • FRES $2.56
  • LTRY $0.92
  • Resistance Level
  • FRES $3.40
  • LTRY $2.20
  • Average True Range (ATR)
  • FRES 0.35
  • LTRY 0.27
  • MACD
  • FRES -0.03
  • LTRY 0.12
  • Stochastic Oscillator
  • FRES 12.69
  • LTRY 72.40

About FRES Fresh2 Group Limited

Fresh2 Group Ltd is a biotechnology company. It focuses on early cancer screening and detection. The company markets and sells a multi-cancer screening and detection test that uses its innovative patented CDA technology and its proprietary CDA device. In addition to early cancer screening and detection, its CDA technology has demonstrated the potential to assist physicians in cancer diagnosis, prognosis, and recurrence.

About LTRY Lottery.com Inc.

Lottery.com Inc is a leading provider of domestic and international lottery products and services. As an independent third-party lottery game service, the Company offers a platform that it developed and operates to enable the remote purchase of legally sanctioned lottery games in the U.S. and abroad. The Company's revenue-generating activities are focused on (i) offering the Platform via the Lottery.com app and its websites to users located in the U.S. and international jurisdictions where the sale of lottery games is legal and its services are enabled for the remote purchase of legally sanctioned lottery games; (ii) offering an internally developed, created and operated business-to-business application programming interface of the Platform to enable commercial partners in permitted U.S.

Share on Social Networks: